Group 1 - Sanbo Brain Science (301293.SZ) released its 2024 annual report on April 18, 2025, with 69 institutional investors holding a total of 54.79 million A-shares, accounting for 26.60% of the total share capital [1] - The top ten institutional investors include TBP 3Doctors (HK) Limited, various products from Taikang Life Insurance Co., Ltd., and others, with a combined holding ratio of 25.80%, which decreased by 5.34 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, 61 new public funds were disclosed this period, including Southern CSI 1000 ETF and others, while one public fund, Dongcai Yuanjian Growth Mixed Initiation A, was no longer disclosed [2] - In the insurance capital sector, two insurance funds reduced their holdings compared to the previous quarter, while one new insurance investor was disclosed, namely Taikang Life Insurance Co., Ltd. - Dividend - Personal Dividend - 019L-FH002 [2]
机构风向标 | 三博脑科(301293)2024年四季度已披露前十大机构持股比例合计下跌5.34个百分点